Year-end report 2018
Mölndal, March 15, 2019 – Vicore Pharma Holding (publ) (ticker: VICO) publish the year-end report for 2018Important events during the fourth quarter · In October, Vicore announced that the rights issue completed in September was oversubscribed by 33% and raised approximately 82 MSEK · In October, Göran Wessman announced his resignation from the board of directors due to health reasons · In November, the board of directors decided to act for the company’s shares to be admitted for trading on the Nasdaq Stockholm’s main list in 2019 · In November, the board of directors